40 patients (37 F) Age 55.4 years (SD 13.2) OHIP-14 11.3 (9.4) Salivary flow 0.78 ± 0.44 ml (min)
23 patients (18 F) Age 56.1 years (SD 17.4) OHIP-14 7.1 (SD 7.6) Salivary flow 1.69 ± 0.59 ml (min)
The decrease in salivary flow and salivary EGF levels associated with pSS progression causes a deterioration of saliva quality contributing to an impairment in oral health
60 (60 F) Age 53.6 years (SD 13.2) OHIP-14 13.5 (SD 10.5) Salivary flow 3.5 ± 2.8 ml (min)
22 patients (22 F) Age 52 years (SD 10.4) OHIP-14 18.6 (SD 13.9) Salivary flow 4.8 ± 1.7 ml (min)
Even though patients affected by sicca syndrome had less severe clinical signs than the pSS patients, they demonstrated much poorer general and oral health-related quality of life